17th European Biosimilars Congress 2024

  • 04-05 Apr 2024
  • Madrid, Spain

Description

The 17th European Biosimilars Congress 2024 covers topics such as:

  • Chemical and Analytical Strategies for Biosimilars
  • Current Challenges in Developing Biosimilars
  • Biological Medicine
  • Intellectual Property Rights
  • Innovative Clinical Approach in Biosimilars
  • Emerging Biosimilars in Therapeutics
  • Biosimilars Development in Markets
  • Regulatory Updates on Biosimilars
  • Biopharmaceutical Informatics
  • Biosimilars Approval to Biogenerics in Clinical Practice
  • BCS and IVIVC Based Biowaivers
  • Consequences of Brexit on Biosimilars
  • Challenges in Biosimilars Pharmacovigilance
  • Biosimilars Market and Cost Analysis
  • Formulation Strategies for Follow-on Biologics
  • Legal Issues and BPCI Act
  • Biosimilars Research Pipeline
  • Current Agency Expectations for Approval for Biosimilars
  • Drug Delivery and Development
  • Globalization of Biosimilars
  • USFDA Approved Biosimilars
  • Monoclonal Antibody Biosimilars

17th European Biosimilars Congress 2024 brings together Heads of Department, Directors, Scientists and Managers of: Product Patrimony, Laboratory Bioanalytics, Biopharmarceutical Technology, Global Marketing & Access, Regulatory Affairs, Strategy, Biopharmaceuticals, Operations, Biotechnical, Business Development and Documentation.

The 17th European Biosimilars Congress 2024 will be held in Madrid, Spain on 04-05 Apr 2024.

Venue

  • Madrid, Spain

More Details

Prices:
99-1500 US Dollar (Estimated)
Exhibition:
Included
Organizer:
Conference Series LLC Ltd
Website:

Future Events

Past Events

Important

Please, check "European Biosimilars Congress" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Medical laboratories, Pharma
Science: Laboratories, Life Sciences & Biology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions